Zhengye Biotechnology Holding (ZYBT) Equity Ratio (2023 - 2024)
Historic Equity Ratio for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to 0.72.
- Zhengye Biotechnology Holding's Equity Ratio changed N/A to 0.72 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.72, marking a year-over-year change of. This contributed to the annual value of 0.71 for FY2024, which is 530.98% up from last year.
- Per Zhengye Biotechnology Holding's latest filing, its Equity Ratio stood at 0.72 for Q2 2025.
- Zhengye Biotechnology Holding's 5-year Equity Ratio high stood at 0.72 for Q2 2025, and its period low was 0.68 during Q4 2023.
- In the last 3 years, Zhengye Biotechnology Holding's Equity Ratio had a median value of 0.71 in 2024 and averaged 0.71.
- Within the past 5 years, the most significant YoY rise in Zhengye Biotechnology Holding's Equity Ratio was 530.98% (2024), while the steepest drop was 530.98% (2024).
- Quarter analysis of 3 years shows Zhengye Biotechnology Holding's Equity Ratio stood at 0.68 in 2023, then increased by 5.31% to 0.71 in 2024, then increased by 1.23% to 0.72 in 2025.
- Its Equity Ratio stands at 0.72 for Q2 2025, versus 0.71 for Q4 2024 and 0.68 for Q4 2023.